Gsk (GSK) FCF Payout Ratio (2009 - 2026)
Gsk (GSK) posted quarterly FCF Payout Ratio of 0.41 for Q1 2026, down 0.92% year-over-year from 0.41 in Q1 2025, and down 64.04% quarter-over-quarter from 0.25 in Q4 2025.
Gsk (GSK) FCF Payout Ratio (2009 - 2026) Analysis & Trends
Gsk's FCF Payout Ratio history runs 18 years deep, the most recent figure standing at 0.41 for Q1 2026.
- In Q1 2026, FCF Payout Ratio fell 0.92% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 0.3 (up 7.93% YoY), while the FY2025 annual figure was 0.34, down 10.74% from the prior year.
- FCF Payout Ratio for Q1 2026 stood at 0.41, down from 0.25 in the prior quarter.
- The five-year high for FCF Payout Ratio was 0.02 in Q3 2023, with the low at 1.07 in Q1 2023.
- The 5-year median for FCF Payout Ratio is 0.35 (2023), against an average of 0.34.
- The sharpest annual moves came in 2023 and 2024: FCF Payout Ratio jumped 82.88% in 2023, then tumbled 1055.48% in 2024.
- Gsk's FCF Payout Ratio stood at 0.46 in 2022, then increased by 25.56% to 0.35 in 2023, then gained by 15.36% to 0.29 in 2024, then rose by 14.62% to 0.25 in 2025, then plunged by 64.04% to 0.41 in 2026.
- Business Quant data shows GSK's FCF Payout Ratio at 0.41 in Q1 2026, 0.25 in Q4 2025, and 0.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.44 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.99 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.48 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.52 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -3.54 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.39 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.30 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 8.12 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.41 |
| Dec 31, 2025 | -0.25 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.41 |
| Dec 31, 2024 | -0.29 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.37 |
| Mar 31, 2024 | -0.41 |
| Dec 31, 2023 | -0.35 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -1.07 |
| Dec 31, 2022 | -0.46 |
| Sep 30, 2022 | -0.13 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -0.40 |
| Dec 31, 2021 | -0.29 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.04 |